Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy

Area of Science:

• Genetics and rare diseases
• Neurology
• Biochemistry

Background:

• Adrenoleukodystrophy (ALD) is a rare, inherited peroxisomal disorder.
• Pathogenic variants in the ABCD1 gene on the X chromosome cause ALD.
• While severe complications primarily affect males, most women with ALD develop adult-onset myeloneuropathy.

Purpose of the Study:

• To identify and review clinical assessment scales used for disease manifestations in women with ALD.
• To provide recommendations for future research objectives.
• To facilitate the development of treatments for symptomatic women with ALD.

Main Methods:

• Scoping review methodology.
• Systematic literature search for studies utilizing clinical rating scales in women with ALD.
• Analysis of identified scales for relevance and sensitivity in capturing disease progression.

Main Results:

• Multiple clinical rating scales have been employed to assess ALD symptoms in women.
• These scales aim to differentiate between asymptomatic and symptomatic individuals.
• Data highlights variability in assessment methods across observational studies.

Conclusions:

• There is a need for standardized, sensitive clinical outcome measures for women with ALD.
• Further research should focus on validating and refining assessment scales.
• Effective outcome measures are crucial for tracking disease progression and evaluating treatment efficacy in women with ALD.